Literature DB >> 8914910

The learning curve for acoustic tumor surgery.

C A Buchman1, D A Chen, P Flannagan, J E Wilberger, J C Maroon.   

Abstract

Although operative experience is considered to be critically important in the surgical management of acoustic tumors, little objective evidence substantiates this claim. The present study was undertaken to determine whether a learning curve exists for acoustic tumor surgery. The first 96 acoustic tumor patients managed surgically by a new neurotologic team were retrospectively reviewed. A significant improvement (P<.0003; F=6.32) in the ability to achieve good (grade II or better) postoperative facial nerve function was identified. Improving trends for complete resection rate and hearing preservation were documented, and the incidence of cerebrospinal fluid (CSF) leaks declined; however, statistical significance was not achieved. For postoperative facial nerve function, approximately 60 cases were necessary before the new team achieved results similar to those of highly experienced surgeons. The frequencies of complete resection, CSF leaks, hearing preservation, stroke, and mortality were comparable to those of experienced neurotologic teams. The findings of this study may have implications for both patient care and physician training.

Entities:  

Mesh:

Year:  1996        PMID: 8914910     DOI: 10.1097/00005537-199611000-00019

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Therapeutic strategy for large vestibular schwannomas.

Authors:  Chul-Kee Park; Hee-Won Jung; Jeong Eun Kim; Young-Je Son; Sun Ha Paek; Dong Gyu Kim
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

3.  Hearing preservation surgery for vestibular schwannomas via the retrosigmoid transmeatal approach: surgical tips.

Authors:  Masahiko Wanibuchi; Takanori Fukushima; Allan H Friedman; Kentaro Watanabe; Yukinori Akiyama; Takeshi Mikami; Satoshi Iihoshi; Tomohiro Murakami; Toshiya Sugino; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2014-04-22       Impact factor: 3.042

4.  Setting the standard--UK neurosurgical acoustic neuroma practice.

Authors:  J R Goodden; R Tranter; C Hardwidge
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

5.  Vestibular schwannoma management: current practice amongst UK otolaryngologists--time for a national prospective audit.

Authors:  Shakeel R Saeed; Ranga Suryanarayanan; Attila Dezso; Richard T Ramsden
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

6.  Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.

Authors:  Kent Tadokoro; Matthew Robert Bartindale; Nadeem El-Kouri; Dennis Moore; Christopher Britt; Matthew Kircher
Journal:  J Neurol Surg B Skull Base       Date:  2021-06-08

7.  Predictors of the risk of mortality in neurofibromatosis 2.

Authors:  Michael E Baser; J M Friedman; Dana Aeschliman; Harry Joe; Andrew J Wallace; Richard T Ramsden; D Gareth R Evans
Journal:  Am J Hum Genet       Date:  2002-08-22       Impact factor: 11.025

8.  Removal of large acoustic neurinomas (vestibular schwannomas) by the retrosigmoid approach with no mortality and minimal morbidity.

Authors:  I Yamakami; Y Uchino; E Kobayashi; A Yamaura; N Oka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

9.  Does Hospital Volume Affect Outcomes in Patients Undergoing Vestibular Schwannoma Surgery?

Authors:  Jonathan L Hatch; Michael J Bauschard; Shaun A Nguyen; Paul R Lambert; Ted A Meyer; Theodore R McRackan
Journal:  Otol Neurotol       Date:  2018-04       Impact factor: 2.311

10.  What really decides the facial function of vestibular schwannoma surgery?

Authors:  Jin Kim; In Seok Moon; Jun Hui Jeong; Hyung Rok Lee; Won Sang Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-12-15       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.